The origin of gastric mutagenesis is resolved, opening therapeutic avenues for curbing ongoing mutagenesis, tumour evolution and drug resistance in gastrointestinal cancers.
One hallmark of pediatric tumors is their low mutational burden, which contrasts with adult tumors, where cancer-causing mutations often accumulate over decades of DNA replication and environmental exposure. This raises the question of how such mutations arise in young patients. We have proposed that developmental mu...
Helen S. Mueller, Kaisha Garvin, Sophia Rha et al.· Cancer Research· 0 citations
Exogenous and endogenous mutagens generate a wide variety of DNA lesions, including bulky adducts, chemical modifications, and single- or double-stranded breaks. A phenomenon called “lesion segregation,” in which lesions evade repair and persist for multiple cell divisions, has recently been documented in tumors and he...
Alkylation chemotherapy is commonly used against tumors such as glioblastoma, yet resistance often develops through downregulation of mismatch repair (MMR). Previous work has established that loss of MMR prevents the excision of the thymine-containing strand across O 6meG-T mismatches, thereby avoiding the futile repai...
Mohamed E. Ashour, Ellissa Krekeler, Monika Chandan Bhowmik et al.· Genes & Development· 0 citations
Persistence of common ultraviolet (UV)–induced lesions, like cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone (6-4) photoproducts (6-4-PPs), typically results in C>T substitutions at dipyrimidines: a mutation pattern that composes the single-base substitution (SBS) signature 7 in cancer. Oncogenic melanom...
Cameron Cordero, Brittany N. Vandenberg, Isabelle Mittelstadt et al.· Science Advances· 0 citations